METTL10
METTL10: An Essential RNA Modifier in Health and Disease
Description
METTL10 is an important enzyme that plays a crucial role in the modification of RNA molecules. This enzyme belongs to a family of enzymes known as RNA methyltransferases, which are responsible for adding methyl groups to specific nucleotides in RNA. METTL10 specifically targets the N6 position of adenosine (A) in RNA, a process known as N6-methyladenosine (m6A) modification.
Associated Diseases
Dysregulation of METTL10 and m6A modification have been implicated in a variety of human diseases, including:
- Cancers: METTL10 has been found to be overexpressed in several types of cancer, including leukemia, breast cancer, and lung cancer. High levels of METTL10 activity can promote tumor growth and metastasis.
- Neurodevelopmental disorders: Aberrant m6A modification by METTL10 has been linked to neurodevelopmental disorders such as autism spectrum disorder and Rett syndrome.
- Cardiovascular diseases: METTL10 has been implicated in the regulation of cardiac function and is associated with cardiovascular diseases such as heart failure and arrhythmias.
- Metabolic disorders: Dysregulation of METTL10 activity has been observed in metabolic disorders such as obesity and diabetes, suggesting a role in glucose metabolism and insulin signaling.
Did you Know ?
Studies have shown that approximately 50% of all RNAs in human cells undergo m6A modification by METTL10. This indicates the widespread importance and prevalence of m6A modification in cellular processes.
